Patent ID: 8622993

Claim:
A method to treat a patient's periodontal disease and the symptomatic anatomical structures innervated by the trigeminal nerve and in need thereof, comprising: providing a delivery device adapted for insertion into the patient's nasal cavity and operative connection with one of the patient's maxillary sinus opening; inserting the delivery device into the patient's nasal cavity until it reaches at least one of the patient's maxillary sinus openings; administering at least one effective dose of at least one therapeutic compound selected from the group consisting of an analgesic, an anesthetic, an anti-inflammatory compound, an antioxidant compound, an antiviral, an antibiotic, and bone morphogenic protein (BMP) via the delivery device through the at least one maxillary sinus opening, wherein the at least one effective dose comprises a volume of at least 0.3 milliliter; depositing the at least one effective dose within the maxillary sinus; and treating the structures innervated by the trigeminal nerve with the at least one therapeutic compound.